Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 4, 2019
MF59-adjuvanted seasonal trivalent inactivated influenza vaccine: Safety and immunogenicity in young children at risk of influenza complicationsSanjay S Patel, Svetlana Bizjajeva, Esther Heijnen, et al.
Haematologica|September 11, 2025
Wild-type p53 overexpression in <i>NPM1</i>-mutated acute myeloid leukemia: potential implications for disease biology and therapy responsePaul D Barone, Siarhei Dzedzik, Ashley S Kleinman, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 17, 2019
Cumulative clinical experience with MF59-adjuvanted trivalent seasonal influenza vaccine in young childrenSanjay S Patel, Svetlana Bizjajeva, Kelly Lindert, et al.
Acta Pharmaceutica (Zagreb, Croatia)|January 22, 2013
Current status and future prospects of drug eluting stents for restenosisMaulik J Patel, Sanjay S Patel, Nidhi S Patel, et al.
Thyroid Research|October 21, 2017
Hyalinizing trabecular tumor of the thyroid gland and its significant diagnostic issueDustin J Jones, Christopher R Kieliszak, Sanjay S Patel, et al.
Blood Advances|June 8, 2021
Effect of DNMT3A variant allele frequency and double mutation on clinicopathologic features of patients with de novo AMLDamodaran Narayanan, Olga Pozdnyakova, Robert P Hasserjian, et al.
Expert Review of Vaccines|March 18, 2025
Pregnancy outcomes following unintentional exposure to TAK-003, a live-attenuated tetravalent dengue vaccineMartina Rauscher, Zeb Youard, Alice Faccin, et al.
Leukemia & Lymphoma|February 5, 2024
Subcutaneous panniculitic-like T-cell lymphoma localized to a site of peginterferon alfa-2a administrationCynthia M Magro, Taylor Kalomeris, Christina R Shreve, et al.
Human Vaccines & Immunotherapeutics|October 17, 2023
An open-label, Phase 3 trial of TAK-003, a live attenuated dengue tetravalent vaccine, in healthy US adults: immunogenicity and safety when administered during the second half of a 24-month shelf-lifeSanjay S Patel, Peter Winkle, Alice Faccin, et al.
Blood Advances|June 22, 2019
External validation and comparison of multiple prognostic scores in allogeneic hematopoietic stem cell transplantationRoni Shouval, Joshua A Fein, Aniela Shouval, et al.
Pageof 7